TSG101 and cancer: According to publicly available information in the Human Protein Atlas (www.proteinatlas.org), most human cancers exhibit a moderate cytoplasmic and membranous immunoreactivity against TSG101, and the intensity of the staining might serve as a prognostic marker for selected cancer types such as hepatocellular and renal tumors.